Casi Pharmaceuticals Inc 's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Casi Pharmaceuticals Inc 's ROA in the fourth quarter of 2025?
Casi Pharmaceuticals Inc recorded a cumulative net loss of $-48 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -162.21%.

However, within the Healthcare sector 930 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 5010.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Total Assets Change	-42.69 %	-50.77 %	-50.77 %	-50.77 %	-47.9 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-48	-39	-39	-39	-39
Return On Assets (TTM)	-162.21 %	-107.83 %	-90.33 %	-77.71 %	-68.19 %
CASIF's Total Ranking	# 5010	#	#	#	# 4830
Total Assets (TTM) in million	36	27	27	27	64
Seq. Total Assets Change	33.04 %	0 %	0 %	-56.92 %	14.29 %
Seq. Net Income Change	-	-	-	-	-

CASIF's 5 Years Annual ROA >> Back to CASIF Management Effectiveness >> Compare CASIF ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 439
Sector	# 931
Overall	# 4975

Return On Assets Statistics
High	Average	Low
-34.89 %	-98.46 %	-187.36 %
(Dec 31 2023)		(Dec 31 2025)

Financial Statements
Casi Pharmaceuticals Inc 's Assets	$ 36 million	CASIF's Balance sheet
Casi Pharmaceuticals Inc 's Income	$ -48 million	Quarterly CASIF's Income Statement
CASIF's Income by Division		See CASIF's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	FY
Y / Y Total Assets Change	-39.86 %	-49.59 %	-29.92 %	-	-
Total Assets in million	36	61	120	171	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-48	-39	-26	-40	0
Annual Return On Assets	-132 %	-64.85 %	-21.86 %	-23.49 %	-

CASIF's 5 Years Annual ROA >> Back to CASIF Management Effectiveness >> Compare CASIF ROA to its Competitors

More Return On Assets Ratios
CASIF's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CASIF's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CASIF's Competitors
Subscribers only: Roa for Casi Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for CASIF's Customers

You may also want to know
CASIF's Roi	CASIF's Inventory Turnover Ratio	CASIF's Growth Rates	CASIF's Dividend Comparisons
	CASIF's Profitability Ratios	CASIF's Asset Turnover Ratio	CASIF's Dividend Growth
CASIF's Roe	CASIF's Valuation Ratios	CASIF's Financial Strength Ratios	CASIF's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector

ROA

Date modified: 2026-07-07T09:43:14+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.